Literature DB >> 19053900

Natural killer cells in immunodefense against infective agents.

Nicolas Zucchini1, Karine Crozat, Thomas Baranek, Scott H Robbins, Marcus Altfeld, Marc Dalod.   

Abstract

Following the discovery of innate immune receptors, the topics of innate immunity and its role in defense against infective agents have recently blossomed into very active research fields, after several decades of neglect. Among innate immune cells, natural killer (NK) cells are endowed with the unique ability to recognize and kill cells infected with a variety of pathogens, irrespective of prior sensitization to these microbes. NK cells have a number of other functions, including cytokine production and immunoregulatory activities. Major advances have recently been made in the understanding of the role of NK cells in the physiopathology of infectious diseases. The cellular and molecular mechanisms regulating the acquisition of effector functions by NK cells and their triggering upon pathogenic encounters are being unraveled. The possibility that the power of NK cells could be harnessed for the design of innovative treatments against infections is a major incentive for biologists to further explore NK cell subset complexity and to identify the ligands that activate NK cell receptors.

Entities:  

Mesh:

Year:  2008        PMID: 19053900      PMCID: PMC2676939          DOI: 10.1586/14787210.6.6.867

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN: 1478-7210            Impact factor:   5.091


  164 in total

Review 1.  Whatever turns you on: accessory-cell-dependent activation of NK cells by pathogens.

Authors:  Kirsty C Newman; Eleanor M Riley
Journal:  Nat Rev Immunol       Date:  2007-04       Impact factor: 53.106

2.  Distinct transcriptional profiles in ex vivo CD4+ and CD8+ T cells are established early in human immunodeficiency virus type 1 infection and are characterized by a chronic interferon response as well as extensive transcriptional changes in CD8+ T cells.

Authors:  Martin D Hyrcza; Colin Kovacs; Mona Loutfy; Roberta Halpenny; Lawrence Heisler; Stuart Yang; Olivia Wilkins; Mario Ostrowski; Sandy D Der
Journal:  J Virol       Date:  2007-01-24       Impact factor: 5.103

3.  Influence of interleukin-15 on CD8+ natural killer cells in human immunodeficiency virus type 1-infected chimpanzees.

Authors:  Annette R Rodriguez; Bernard P Arulanandam; Vida L Hodara; Hazel M McClure; Elaine K Cobb; Mary T Salas; Robert White; Krishna K Murthy
Journal:  J Gen Virol       Date:  2007-02       Impact factor: 3.891

4.  NKp30-dependent cytolysis of filovirus-infected human dendritic cells.

Authors:  Claudette L Fuller; Gordon Ruthel; Kelly L Warfield; Dana L Swenson; Catharine M Bosio; M Javad Aman; Sina Bavari
Journal:  Cell Microbiol       Date:  2007-04       Impact factor: 3.715

5.  NKp46 and NKG2D recognition of infected dendritic cells is necessary for NK cell activation in the human response to influenza infection.

Authors:  Monia Draghi; Achal Pashine; Bharati Sanjanwala; Ketevan Gendzekhadze; Claudia Cantoni; David Cosman; Alessandro Moretta; Nicholas M Valiante; Peter Parham
Journal:  J Immunol       Date:  2007-03-01       Impact factor: 5.422

6.  Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46.

Authors:  Thierry Walzer; Mathieu Bléry; Julie Chaix; Nicolas Fuseri; Lionel Chasson; Scott H Robbins; Sébastien Jaeger; Pascale André; Laurent Gauthier; Laurent Daniel; Karine Chemin; Yannis Morel; Marc Dalod; Jean Imbert; Michel Pierres; Alessandro Moretta; François Romagné; Eric Vivier
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-20       Impact factor: 11.205

7.  Cutting Edge: Allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B.

Authors:  Hathairat Thananchai; Geraldine Gillespie; Maureen P Martin; Arman Bashirova; Nobuyo Yawata; Makoto Yawata; Philippa Easterbrook; Daniel W McVicar; Katsumi Maenaka; Peter Parham; Mary Carrington; Tao Dong; Sarah Rowland-Jones
Journal:  J Immunol       Date:  2007-01-01       Impact factor: 5.422

8.  Expression of ICP0 is sufficient to trigger natural killer cell recognition of herpes simplex virus-infected cells by natural cytotoxicity receptors.

Authors:  Susan E Chisholm; Keith Howard; Mar Valés Gómez; Hugh T Reyburn
Journal:  J Infect Dis       Date:  2007-03-02       Impact factor: 5.226

9.  Dissection of the role of PfEMP1 and ICAM-1 in the sensing of Plasmodium-falciparum-infected erythrocytes by natural killer cells.

Authors:  Myriam Baratin; Sophie Roetynck; Bruno Pouvelle; Céline Lemmers; Nicola K Viebig; Sofia Johansson; Philippe Bierling; Artur Scherf; Jürg Gysin; Eric Vivier; Sophie Ugolini
Journal:  PLoS One       Date:  2007-02-21       Impact factor: 3.240

10.  Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage.

Authors:  Claire Dunn; Maurizia Brunetto; Gary Reynolds; Theodoros Christophides; Patrick T Kennedy; Pietro Lampertico; Abhishek Das; A Ross Lopes; Persephone Borrow; Kevin Williams; Elizabeth Humphreys; Simon Afford; David H Adams; Antonio Bertoletti; Mala K Maini
Journal:  J Exp Med       Date:  2007-03-12       Impact factor: 14.307

View more
  12 in total

Review 1.  Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target.

Authors:  Kenneth L Becker; Richard Snider; Eric S Nylen
Journal:  Br J Pharmacol       Date:  2009-11-27       Impact factor: 8.739

2.  Regulation of human NK-cell cytokine and chemokine production by target cell recognition.

Authors:  Cyril Fauriat; Eric O Long; Hans-Gustaf Ljunggren; Yenan T Bryceson
Journal:  Blood       Date:  2009-12-01       Impact factor: 22.113

Review 3.  Innate immune cell response upon Candida albicans infection.

Authors:  Yulin Qin; Lulu Zhang; Zheng Xu; Jinyu Zhang; Yuan-Ying Jiang; Yongbing Cao; Tianhua Yan
Journal:  Virulence       Date:  2016-04-14       Impact factor: 5.882

4.  Healthy Neonates Possess a CD56-Negative NK Cell Population with Reduced Anti-Viral Activity.

Authors:  Amanda Jacobson; Frank Bell; Nicholas Lejarcegui; Caroline Mitchell; Lisa Frenkel; Helen Horton
Journal:  PLoS One       Date:  2013-06-21       Impact factor: 3.240

5.  Is Infant Immunity Actively Suppressed or Immature?

Authors:  Ana L Gervassi; Helen Horton
Journal:  Virology (Auckl)       Date:  2014

6.  FHL2 Regulates Natural Killer Cell Development and Activation during Streptococcus pneumoniae Infection.

Authors:  Thomas Baranek; Eric Morello; Alexandre Valayer; Rose-France Aimar; Déborah Bréa; Clemence Henry; Anne-Gaelle Besnard; Emilie Dalloneau; Antoine Guillon; Pierre-François Dequin; Emilie Narni-Mancinelli; Eric Vivier; Fabrice Laurent; Yu Wei; Christophe Paget; Mustapha Si-Tahar
Journal:  Front Immunol       Date:  2017-02-13       Impact factor: 7.561

Review 7.  Natural killer cells as a therapeutic tool for infectious diseases - current status and future perspectives.

Authors:  Stanislaw Schmidt; Lars Tramsen; Bushra Rais; Evelyn Ullrich; Thomas Lehrnbecher
Journal:  Oncotarget       Date:  2018-04-17

Review 8.  Flattening the COVID-19 Curve With Natural Killer Cell Based Immunotherapies.

Authors:  Marisa Market; Leonard Angka; Andre B Martel; Donald Bastin; Oladunni Olanubi; Gayashan Tennakoon; Dominique M Boucher; Juliana Ng; Michele Ardolino; Rebecca C Auer
Journal:  Front Immunol       Date:  2020-06-23       Impact factor: 7.561

9.  Clinical pharmacology of alemtuzumab, an anti-CD52 immunomodulator, in multiple sclerosis.

Authors:  Z Li; S Richards; H K Surks; A Jacobs; M A Panzara
Journal:  Clin Exp Immunol       Date:  2018-10-01       Impact factor: 4.330

Review 10.  Vitamin D and Allergy Susceptibility during Gestation and Early Life.

Authors:  Daniela Briceno Noriega; Huub F J Savelkoul
Journal:  Nutrients       Date:  2021-03-21       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.